| P50 | author | Richard Lee | Q87982694 |
| | Steven A Kaplan | Q88176270 |
| P2093 | author name string | Bilal Chughtai | |
| | Alexis Te | |
| P2860 | cites work | Distribution of Inflammation, Pre-Malignant Lesions, Incidental Carcinoma in Histologically Confirmed Benign Prostatic Hyperplasia: A Retrospective Analysis | Q62660534 |
| | Prostatic inflammation in benign prostatic hyperplasia - the third component? | Q73592641 |
| | Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium | Q80403759 |
| | Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? | Q80580892 |
| | Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial | Q31118951 |
| | Chronic prostatitis-an infectious disease? | Q33996326 |
| | Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. | Q34200792 |
| | Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels | Q34294207 |
| | Inflammation and benign prostatic hyperplasia | Q36380033 |
| | BPH: epidemiology and comorbidities | Q36448658 |
| | BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. | Q37097043 |
| | A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer. | Q37581028 |
| | Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis. | Q39438002 |
| | Treatment of experimental autoimmune prostatitis in nonobese diabetic mice by the vitamin D receptor agonist elocalcitol | Q42505016 |
| | Inflammation and prostate cancer | Q44289840 |
| | The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways | Q46183765 |
| | Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study | Q46436243 |
| | BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay. | Q53853603 |
| P433 | issue | 3 | |
| P921 | main subject | prostatic hypertrophy | Q506659 |
| P304 | page(s) | 147-150 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Reviews in urology | Q26853801 |
| P1476 | title | Role of inflammation in benign prostatic hyperplasia | |
| P478 | volume | 13 | |